Form 483

Guy & O'Neill, Inc. Form 483, 2021-10-29

FDA issued a Form 483 to Guy & O'Neill, Inc. on 2021-10-29 with 5 public-safe observations.

483· Form 483 issuedMedical Devices & Rad Health5 observations

Guy & O'Neill, Inc. · Fredonia, United States · Issued October 29, 2021

Overview

  • 5 public-safe observations are available for this inspection.
  • 5 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

29 Oct 2021
21 CFR 820.100(a)

Lack of or inadequate procedures

Cited by Michelle J Glembin, Nicholas T Domer

29 Oct 2021
21 CFR 820.150

Lack of or inadequate procedures for storage.

Cited by Michelle J Glembin, Nicholas T Domer

29 Oct 2021
21 CFR 820.22

Quality audits - Lack of or inadequate procedures

Cited by Michelle J Glembin, Nicholas T Domer

29 Oct 2021
21 CFR 820.75(a)

Lack of or inadequate process validation

Cited by Michelle J Glembin, Nicholas T Domer

29 Oct 2021
21 CFR 820.90(a)

Nonconforming product, Lack of or inadequate procedures

Cited by Michelle J Glembin, Nicholas T Domer

Inspected site

G&Guy & O'Neill, Inc.Fredonia, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 820.100(a)Cited across public-safe Form 483 observations1x
21 CFR 820.150Cited across public-safe Form 483 observations1x
21 CFR 820.22Cited across public-safe Form 483 observations1x
21 CFR 820.75(a)Cited across public-safe Form 483 observations1x
21 CFR 820.90(a)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 5 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere